SEC Filing Details
Document Details
Form
Filing Date
Apr 9, 2019
Document Date
Apr 5, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Merrimack Pharmaceuticals
Issuer
MERRIMACK PHARMACEUTICALS INC
Filer
22NW Fund, LP